Inventaire - your friends and communities are your best library

A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure

Author

Jeanne Mialet-Perez

Laura C. Lazzeroni

William T Abraham

published in: Proceedings of the National Academy of Sciences of the United States of America

date of publication: 2006-07-14

language: English

main subject: heart failure

Bibliographic databases:

Cites articles 36

Date

Title

Authors

1958-06

Nonparametric Estimation from Incomplete Observations

,
1980-02-01

β-adrenoceptor and cardiovascular effects of MJ 13105 (Bucindolol) in anesthetized dogs and rats
1982-10-01

The cardiovascular effects of ICI 118,587: A beta 1-adrenoceptor partial agonist
1982-07-01

Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts,Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts
1986-09-01

Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure
1989-03

Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium
1990-03-01

Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo
1990-06-01

Mechanism of Action of Bucindolol in Human Ventricular Myocardium
1990-01-01

Amplification of cyclic AMP generation reveals agonistic effects of certain beta-adrenergic antagonists
1990-07-01

Xamoterol in severe heart failure. The Xamoterol in Severe Heart Failure Study Group
1995-06-01

Design of the Beta-Blocker Evaluation Survival Trial (BEST). The BEST Steering Committee
1995-10-01

Cardiac beta-adrenergic neuroeffector systems in acute myocardial dysfunction related to brain injury. Evidence for catecholamine-mediated myocardial damage
1997-11-01

Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium
1998-01-01

Ejection fraction improvement by beta-blocker treatment in patients with heart failure: an analysis of studies published in the literature,Ejection Fraction Improvement by β-Blocker Treatment in Patients with Heart Failure: An Analysis of Studies Published in the Literature
1998-12-01

The role of third-generation beta-blocking agents in chronic heart failure
1999-09-19

Racial differences in the frequencies of cardiac beta(1)-adrenergic receptor polymorphisms: analysis of c145A>G and c1165G>C
1999-04-30

A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor
1999-06-12

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
1999-04-01

In vitro and in vivo characterization of intrinsic sympathomimetic activity in normal and heart failure rats
2000-08-04

Crystal structure of rhodopsin: A G protein-coupled receptor

,
2000-07-01

Different intrinsic activities of bucindolol, carvedilol and metoprolol in human failing myocardium
2001-05-01

Effect of carvedilol on survival in severe chronic heart failure

,
2001-05-01

Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure
2001-03-01

Pharmacogenetic applications of the Human Genome project
2001-05-01

A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure
2002-05-01

Bucindolol displays intrinsic sympathomimetic activity in human myocardium
2002-01-01

Identification of adrenergic receptor polymorphisms
2003-03-01

Antiadrenergic therapy of chronic heart failure: surprises and new opportunities
2003-09-14

Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure,β1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure
2003-07-07

Partial agonist activity of bucindolol is dependent on the activation state of the human beta1-adrenergic receptor

, ,
2003-08-01

An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals with heart failure: a MERIT-HF sub-study

, ,
2004-08-30

Effect of baseline or changes in adrenergic activity on clinical outcomes in the beta-blocker evaluation of survival trial

,

Article -

Welcome to inventaire

The library of your friends and communities

Learn more